HK1201050A1 - 多肽和它們的用途 - Google Patents

多肽和它們的用途

Info

Publication number
HK1201050A1
HK1201050A1 HK15101528.2A HK15101528A HK1201050A1 HK 1201050 A1 HK1201050 A1 HK 1201050A1 HK 15101528 A HK15101528 A HK 15101528A HK 1201050 A1 HK1201050 A1 HK 1201050A1
Authority
HK
Hong Kong
Prior art keywords
polypeptides
Prior art date
Application number
HK15101528.2A
Other languages
English (en)
Inventor
‧奧尼爾
‧莫瑟爾
‧斯圖爾特
Original Assignee
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd
Publication of HK1201050A1 publication Critical patent/HK1201050A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
HK15101528.2A 2012-03-14 2015-02-11 多肽和它們的用途 HK1201050A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use
US201261620833P 2012-04-05 2012-04-05
PCT/GB2013/000112 WO2013136040A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Publications (1)

Publication Number Publication Date
HK1201050A1 true HK1201050A1 (zh) 2015-08-21

Family

ID=46026493

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101528.2A HK1201050A1 (zh) 2012-03-14 2015-02-11 多肽和它們的用途

Country Status (17)

Country Link
US (1) US20140155321A1 (zh)
EP (1) EP2825261A1 (zh)
JP (1) JP2015516943A (zh)
KR (1) KR20140138940A (zh)
CN (1) CN104428036A (zh)
AU (1) AU2013234122A1 (zh)
CA (1) CA2866837A1 (zh)
CL (1) CL2014002397A1 (zh)
GB (1) GB201204457D0 (zh)
HK (1) HK1201050A1 (zh)
IL (1) IL234646A0 (zh)
MX (1) MX2014010996A (zh)
NZ (1) NZ700467A (zh)
RU (1) RU2014139857A (zh)
SG (1) SG11201405539QA (zh)
WO (1) WO2013136040A1 (zh)
ZA (1) ZA201407276B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6596098B2 (ja) * 2015-04-03 2019-10-23 イーエルシー マネージメント エルエルシー 毛髪処理組成物
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
WO2017047299A1 (ja) * 2015-09-15 2017-03-23 富士フイルム株式会社 注射用液剤組成物
CN109700834A (zh) * 2019-01-18 2019-05-03 上海市农业科学院 一种蛹虫草固体发酵物及其抗菌用途
CN115381928B (zh) * 2022-10-27 2022-12-27 山东中医药大学附属医院 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5020078B2 (ja) * 2004-08-18 2012-09-05 ノバビオティクス・リミテッド ペプチド
GB0611115D0 (en) * 2006-06-06 2006-07-19 Novabiotics Ltd Compounds and their use
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702022D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
US8765688B2 (en) * 2007-12-21 2014-07-01 Basf Se Anti-dandruff compositions containing peptides

Also Published As

Publication number Publication date
SG11201405539QA (en) 2014-10-30
CL2014002397A1 (es) 2015-02-27
MX2014010996A (es) 2014-10-13
IL234646A0 (en) 2014-11-30
US20140155321A1 (en) 2014-06-05
KR20140138940A (ko) 2014-12-04
ZA201407276B (en) 2015-06-24
GB201204457D0 (en) 2012-04-25
NZ700467A (en) 2016-08-26
CA2866837A1 (en) 2013-09-19
JP2015516943A (ja) 2015-06-18
AU2013234122A1 (en) 2014-10-16
RU2014139857A (ru) 2016-05-10
EP2825261A1 (en) 2015-01-21
WO2013136040A1 (en) 2013-09-19
CN104428036A (zh) 2015-03-18

Similar Documents

Publication Publication Date Title
HK1210790A1 (zh) 修飾的因子 多肽及其應用
HK1203493A1 (zh) 取代的氮雜雙環及其用途
HK1202545A1 (zh) 新型二氮雜螺環烷烴和氮雜螺環烷烴
EP2870170A4 (en) NOVEL PEPTIDES AND THEIR USE
GB201201100D0 (en) Polypeptides and methods
HK1210949A1 (zh) 組合及其用途
SG11201501646PA (en) Peptides and their uses
HK1203198A1 (zh) 取代的苯基咪唑並吡唑及其用途
HK1205747A1 (zh) 經修飾脂聯素多肽和其用途
HK1201050A1 (zh) 多肽和它們的用途
HK1210809A1 (zh) β己糖基轉移酶及其用法
HK1211042A1 (zh) 炎症促發多肽及其用途
ZA201504462B (en) TGFß-DERIVED POLYPEPTIDES AND USES THEREOF
EP2918600A4 (en) NEW PEPTIDE AND ITS USE
HK1207154A1 (zh) -脂聯素複合物及其用途
GB201210303D0 (en) Polypeptides and methods
GB201214769D0 (en) Methodsa and peptides
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder